Neuvasq Biotechnologie is pleased to announce the appointment of Ralph Laufer, Ph.D., as its Chief…

Neuvasq Biotechnologies appoints World-Leading Experts to newly formed Scientific Advisory Board dedicated to its CNS…

Event site: https://informaconnect.com/bioeurope/

Event site: https://conferences.biocentury.com/bioequity-europe-2023

Neuvasq moves to the ULB Open Lab where it will rent a full equipped lab…

Neuvasq Biotechnologies, a ULB spin-off developing pharmaceuticals to restore blood-brain barrier function, announces the appointment…

The laboratory of Benoit Vanhollebeke published a paper in the journal Science on an innovative…

Newton together with public and private investment partners invests in Neuvasq for the development of…